Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

GLP-1 Agonists

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Researchers say weight loss and metabolic changes may explain the link as they move to launch multisite randomized trials to test whether the drugs can prevent breast cancer

41 ARTICLES

4mo ago

Oval Office Event Pauses as Pharma Representative Faints During Trump’s GLP-1 Pricing Announcement

21 ARTICLES

10mo ago

ESC Data Tie Wegovy and Mounjaro to Lower HFpEF Hospitalization and Death, With Novo Citing CV Edge for Wegovy

GLP-1 Agonists

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

GLP-1 Boom Hits a Crossroads as States Cut Coverage and Next‑Gen Drugs Advance

Oval Office Event Pauses as Pharma Representative Faints During Trump’s GLP-1 Pricing Announcement

ESC Data Tie Wegovy and Mounjaro to Lower HFpEF Hospitalization and Death, With Novo Citing CV Edge for Wegovy